178 related articles for article (PubMed ID: 28413963)
21. Pharmacogenomics of cantharidin in tumor cells.
Kadioglu O; Kermani NS; Kelter G; Schumacher U; Fiebig HH; Greten HJ; Efferth T
Biochem Pharmacol; 2014 Feb; 87(3):399-409. PubMed ID: 24231507
[TBL] [Abstract][Full Text] [Related]
22. Serine/threonine protein phosphatase inhibition enhances the effect of thymidylate synthase inhibition.
Sakoff JA; Howitt IJ; Ackland SP; McCluskey A
Cancer Chemother Pharmacol; 2004 Mar; 53(3):225-32. PubMed ID: 14648018
[TBL] [Abstract][Full Text] [Related]
23. Changes in glutathione, oxidative stress and mitochondrial membrane potential in apoptosis involving the anticancer activity of cantharidin isolated from redheaded blister beetles, epicauta hirticornis.
Verma AK; Prasad SB
Anticancer Agents Med Chem; 2013 Sep; 13(7):1096-114. PubMed ID: 23343079
[TBL] [Abstract][Full Text] [Related]
24. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
Li YM; Mackintosh C; Casida JE
Biochem Pharmacol; 1993 Oct; 46(8):1435-43. PubMed ID: 8240393
[TBL] [Abstract][Full Text] [Related]
25. Antitumor potential of the protein phosphatase inhibitor, cantharidin, and selected derivatives.
Ren Y; Kinghorn AD
Bioorg Med Chem; 2021 Feb; 32():116012. PubMed ID: 33454654
[TBL] [Abstract][Full Text] [Related]
26. Optically active cantharidin analogues possessing selective inhibitory activity on Ser/Thr protein phosphatase 2B (calcineurin): implications for the binding mode.
Baba Y; Hirukawa N; Sodeoka M
Bioorg Med Chem; 2005 Sep; 13(17):5164-70. PubMed ID: 15951185
[TBL] [Abstract][Full Text] [Related]
27. The effects of cantharidin analogues on xanthine oxidase.
Tsauer W; Lin JG; Lin PY; Hsu FL; Chiang HC
Anticancer Res; 1997; 17(3C):2095-8. PubMed ID: 9216670
[TBL] [Abstract][Full Text] [Related]
28. A synthetic cantharidin analog for the enhancement of doxorubicin suppression of stem cell-derived aggressive sarcoma.
Zhang C; Peng Y; Wang F; Tan X; Liu N; Fan S; Wang D; Zhang L; Liu D; Wang T; Wang S; Zhou Y; Su Y; Cheng T; Zhuang Z; Shi C
Biomaterials; 2010 Dec; 31(36):9535-43. PubMed ID: 20875681
[TBL] [Abstract][Full Text] [Related]
29. Cantharidin and norcantharidin inhibit caprine luteal cell steroidogenesis in vitro.
Twu NF; Srinivasan R; Chou CH; Wu LS; Chiu CH
Exp Toxicol Pathol; 2012 Jan; 64(1-2):37-44. PubMed ID: 20594813
[TBL] [Abstract][Full Text] [Related]
30. Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin).
Baba Y; Hirukawa N; Tanohira N; Sodeoka M
J Am Chem Soc; 2003 Aug; 125(32):9740-9. PubMed ID: 12904040
[TBL] [Abstract][Full Text] [Related]
31. Norcantharidin analogues: a patent review (2006 - 2010).
Deng L; Tang S
Expert Opin Ther Pat; 2011 Nov; 21(11):1743-53. PubMed ID: 22017412
[TBL] [Abstract][Full Text] [Related]
32. Structural basis of serine/threonine phosphatase inhibition by the archetypal small molecules cantharidin and norcantharidin.
Bertini I; Calderone V; Fragai M; Luchinat C; Talluri E
J Med Chem; 2009 Aug; 52(15):4838-43. PubMed ID: 19601647
[TBL] [Abstract][Full Text] [Related]
33. Cantharidin impedes the activity of protein serine/threonine phosphatase in Plutella xylostella.
Chen X; Liu J; Zhang Y
Mol Biosyst; 2014 Feb; 10(2):240-50. PubMed ID: 24253262
[TBL] [Abstract][Full Text] [Related]
34. Interactions of cantharidin-like inhibitors with human protein phosphatase-5 in a Mg
Assis LC; de Castro AA; Prandi IG; Mancini DT; de Giacoppo JOS; Savedra RML; de Assis TM; Carregal JB; da Cunha EFF; Ramalho TC
J Mol Model; 2018 Oct; 24(10):303. PubMed ID: 30280322
[TBL] [Abstract][Full Text] [Related]
35. Cantharidin and norcantharidin inhibit the ability of MCF-7 cells to adhere to platelets via protein kinase C pathway-dependent downregulation of α2 integrin.
Shou LM; Zhang QY; Li W; Xie X; Chen K; Lian L; Li ZY; Gong FR; Dai KS; Mao YX; Tao M
Oncol Rep; 2013 Sep; 30(3):1059-66. PubMed ID: 23835679
[TBL] [Abstract][Full Text] [Related]
36. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
37. Cantharidin for the treatment of molluscum contagiosum: a prospective, double-blinded, placebo-controlled trial.
Coloe Dosal J; Stewart PW; Lin JA; Williams CS; Morrell DS
Pediatr Dermatol; 2014; 31(4):440-9. PubMed ID: 22897595
[TBL] [Abstract][Full Text] [Related]
38. Inhibitory effect of cantharidin on osteoclast differentiation and bone resorption.
Kim MH; Shim KS; Kim SH
Arch Pharm Res; 2010 Mar; 33(3):457-62. PubMed ID: 20361312
[TBL] [Abstract][Full Text] [Related]
39. Safety of cantharidin: a retrospective review of cantharidin treatment in 405 children with molluscum contagiosum.
Moye VA; Cathcart S; Morrell DS
Pediatr Dermatol; 2014; 31(4):450-4. PubMed ID: 24383663
[TBL] [Abstract][Full Text] [Related]
40. Cantharidin revisited: a blistering defense of an ancient medicine.
Moed L; Shwayder TA; Chang MW
Arch Dermatol; 2001 Oct; 137(10):1357-60. PubMed ID: 11594862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
